Elastin-elastase-atherosclerosis revisited

Atherosclerosis

Volumn 140, Issue 2, 1998, Pages 281-295

  Robert, L ^a,b   Robert, A M ^a,b   Jacotot, B ^c  

^a SORBONNE UNIVERSITÉ   (France)

^b Lab de Recherche Ophtalmologique   (France)

^c Service de Médecine Interne 5   (France)

Author keywords

Aging; Atherosclerosis; Blood lipids; Elastase; Elastin

Indexed keywords

CHOLESTEROL; ELASTASE; ELASTIN; FIBRONECTIN; LIPID; LIPOPROTEIN; NITRIC OXIDE;

AGING; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL WALL; CHOLESTEROL SYNTHESIS; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HUMAN; LIPID BLOOD LEVEL; LIPID METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; VASODILATATION;

ADULT; AGED; AGING; ANIMALS; ARTERIES; ARTERIOSCLEROSIS; CHOLESTEROL; ELASTIN; EXTRACELLULAR MATRIX; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC ELASTASE; RABBITS; RISK FACTORS; VASODILATION;

EID: 0031728107     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00171-3     Document Type: Review

References (86)

1. Robert B., Robert L., Robert A.M. Elastine, élastase et artériosclérose. Pathol. Biol. 22:1974;661-669.
2. Robert L., Robert A.M. Elastin, elastase and arteriosclerosis. Robert A.M., Robert L. Frontiers of matrix biology. 8:1980;130-173 Karger, Basel.
3. Berenson G.S. Cardiovascular risk factors in children. 1980;Oxford University Press, New York.
4. Haust M.D. The genesis of atherosclerosis in pediatric age-group. J. Pediatric. Pathol. 10:1990;253-271.
5. Burger M. Altern und Krankheit. 1947;Georg Thieme, Leipzig.
6. Gariepy J., Simon A., Massonneau M., Linhart A., Levenson J. Wall thickening of carotid and femoral arteries in male subjects with isolated hypercholesterolemia. Atherosclerosis. 113:1995;141-151.
7. Robert L., Labat-Robert J. Aging of extracellular matrix, its role in the development of age-associated diseases. Bergener M., Ermini M., Stähelin H.B. Crossroads in aging. 1988;105-126 Academic Press, London.
8. Ouzilou J., Robert A.M., Robert L., Bouissou H., Pieraggi M.T. Etude sur la composition de la paroi aortique normale et athéroscléreuse. Paroi. Artérielle. 1:1973;105-116.
9. Moczar M., Robert L. Extraction and fractionation of the media of the thoracic aorta. Isolation and characterization of structural glycoproteins. Atherosclerosis. 11:1970;7-25.
10. Robert L., Chadwick D. The molecular biology and pathology of elastic tissues (Ciba Foundation Symposium 192). 1995;Wiley, Chichester.
11. Robert B., Szigeti M., Derouette J.C., Robert L., Bouissou H., Fabre M.T. Studies on the nature of the microfibrillar component of elastic fibers. Eur. J. Biochem. 21:1971;507-516.
12. Balo J. Connective tissue changes in atherosclerosis. Hall D.A. International review of connective tissue research. I:1963;241-306 Academic Press, New York.
13. Partridge S.M. Elastin. Anfinsen C.B., Anson M.L., Bailey K., Edsall J.T. Advances in protein chemistry. 1962;227-302 Academic Press, New York.
14. Robert L., Hornebeck W. Elastin and elastases. I:1989;CRC Press, Boca Raton, FL.
15. Janoff A., Scherer J. Mediators of inflammation in leukocyte lysosomes. IX. Elastinolytic activity in granules of human polymorphonuclear leucocytes. J. Exp. Med. 128:1968;1137-1140.
16. Robert B., Legrand Y., Pignaud G., Caen J., Robert L. Activité élastinolytique associée aux plaquettes sanguines. Pathol. Biol. 17(11-14):1969;615-622.
17. Legrand Y., Caen J., Booyse F.M., Rafelson M.E., Robert B., Robert L. Studies on a human blood platelet protease with elastolytic activity. Biochim. Biophys. Acta. 309:1973;406-413.
18. Robert B., Derouette J.C., Robert L. Mise en évidence d'une protéase à activité élastolytique dans les extraits d'aortes humaines et animales. CR. Acad. Sci. 278:1974;3251-3254.
19. Robert B., Robert L. Aortic elastase, its role in the degradation of arterial elastin. Peeters H. Protids in biological fluids. 1975;419-424 Pergamon Press, New York.
20. Hornebeck W., Derouette J.C., Robert L. Isolation, purification and properties of aortic elastase. FEBS. Lett. 58:1975;66-70.
21. Bourdillon M.C., Brechemier D., Blaes N., Derouette J.C., Hornebeck W., Robert L. Elastase-like enzymes in skin fibroblasts and rat aorta smooth muscle cells. Cell. Biol. Int. 4:1980;313-320.
22. Brechemier D., Hornebeck W., Bourdillon M.C., Blaes N., Crouzet B., Robert L. Elastase-like proteases in rat aorta smooth muscle cells and fibroblasts. Artery. 8:1980;342-347.
23. Hornebeck W., Adnet J.J., Robert L. Age dependent variation of elastin and elastase in aorta and human breast cancers. Exp. Gerontol. 13:1978;293-298.
24. Robert L., Labat-Robert J., Hornebeck W. Aging and atherosclerosis. Gotto A.M., Paoletti R. Atherosclerosis reviews. 1986;143-170 Raven Press, New York.
25. Robert L., Hornebeck W. Elastin and elastases. II:1989;CRC Press, Boca Raton, FL.
26. Thompson K., Kobayashi J., Childs T., Wigle D., Rabinovitch M. Endothelial and serum factors which include apolipoprotein A1 tether elastin to smooth muscle cells inducing serine elastase activity via tyrosine kinase-mediated transcription and translation. J. Cell. Physiol. 174:1998;78-89.
27. Bernard E., Hornebeck W., Robert L. L'endopeptidase de type élastase des fibroblastes. Effet des inhibiteurs des métalloprotéases. CR. Acad. Sci. 318:1995;179-182.
28. Hornebeck W., Derouette J.C., Roland J., Chatelet F., Bouissou H., Robert L. Corrélation entre l'âge, l'artériosclérose et l'activité élastinolytique de la paroi aortique humaine. CR. Acad. Sci. 292:1976;2003-2006.
29. Hayflick L. The cellular basis for biological aging. Brody H., Rossman I., Marott Sinex F. Handbook of the biology of aging. 1977;159-186 VNR, New York.
30. Ross R., Wight T.N., Strandness E., Thiele B. Human atherosclerosis. Am. J. Pathol. 114:1984;79-93.
31. Li Z, Froehlich J, Galis ZS, Lakatta EG. Increased expression of matrix metalloproteinase-2 (MMP-2) in the thickened intima of aged rats. 1998, submitted.
32. Imai S.I., Nishibayashi S., Takao K., Tomifuji M., Fujino T., Hasegawa M., Takano T. Dissociation of oct-1 from the nuclear peripheral structure induces the cellular aging-associated collagenase gene expression. Mol. Biol. Cell. 8:1997;2407-2419.
33. 14C-cholesterol in the macromolecular fractions of rat connective tissues. Conn. Tissue. Res. 1:1972;145-152.
34. Claire M., Jacotot B., Robert L. Characterization of lipids associated with macromolecules of the intercellular matrix of human aorta. Conn. Tissue. Res. 4:1976;61-71.
35. Robert L., Chaudiere J., Jacotot B. Interaction between lipids and the intercellular matrix of the arterial wall: its role in the evolution of atherosclerotic lesions. Malinow M.R., Blaton V.H. Regression of atherosclerosis lesions. Experimental studies and observations in humans (NATO SI series, Life Sciences). 1984;145-173 Plenum Press, London.
36. Jacotot B., Beaumont J.L., Monnier G., Szigeti M., Robert B., Robert L. Role of elastic tissue in cholesterol deposition in the arterial wall. Nutr. Metab. 15:1973;46-58.
37. Urry D.W., Luan C.H., Peng S.Q. Molecular biophysics of elastin structure, function and pathology. Robert L., Chadwick D. The molecular biology and pathology of elastic tissues (Ciba Foundation Symposium 192). 1995;Wiley, Chichester.
38. Jacob M.P., Hornebeck W., Robert L. Studies on the interaction of cholesterol with soluble and insoluble elastins. Int. J. Biol. Macromol. 5:1983;275-278.
39. Urry D.W. Sequential polypeptides of elastin: structural properties and molecular pathologies. Robert A.M., Robert L. Frontiers of matrix biology. 1980;78-103 Karger, Basel.
40. Lansing A.I., Rosenthal T.B., Alex M., Dempsey E.W. The structure and characterization of elastic fibers as revealed by elastase and electron microscopy. Anat. Rec. 114:1952;555-570.
41. Jacob M.P., Brechemier D., Robert L., Hornebeck W. Variation of elastase-type protease activity and elastin biosynthesis in rabbit aorta induced by cholesterol diet. Artery. 10:1982;310-316.
42. Bourdillon M.C., Hornebeck W., Soleilhac J.M., Robert L. Smooth muscle cell elastase: effect of in vitro ageing and lipoproteins. Biochem. Soc. Trans. 12:1984;876.
43. Hornebeck W., Robert L. Transition of smooth muscle cells from the quiescent to the proliferative form. Role of elastonectin and plasma membrane elastase-type protease. Gallo L.L. Cardiovascular disease molecular and cellular mechanisms: prevention and treatment. 1987;219-225 Plenum Press, London.
44. Pelletier-Lebon P., Hornebeck W., Dachet C., Jacotot B., Robert L. Effect of lipoproteins on the elastase activity expressed by human skin fibroblasts in culture. Cell. Biol. Int. 12:1988;449-457.
45. Hornebeck W., Homsy R., Pelletier-Lebon P., Ayrault-Jarrier M., Robert L. Characterization of a metalloproteinase (proteinase A1) associated with human HDL; its involvement in apo A1 catabolism. Dingle J.T., Barrett A.J., Reynolds J.J. The control of tissue damage. 1987;174-175 Strangeways Research Lab, Cambridge.
46. Chaudiere J., Derouette J.C., Mendy F., Jacotot B., Robert L. In vitro preparation of elastin-triglyceride complexes. Fatty acid uptake and modification of the susceptibility to elastase action. Atherosclerosis. 36:1980;183-194.
47. Ouzilou J., Courtois Y., Moczar M., Robert L. Biosynthèse des macromolécules de la matrice intercellulaire en culture d'organe d'aorte. Influence de l'âge de l'animal. CR. Acad. Sci. 280:1975;209-212.
48. Moczar M., Ouzilou J., Courtois Y., Robert L. Age dependence of the biosynthesis of intercellular matrix macromolecules of rabbit aorta in organ culture and cell culture. Gerontology. 22:1976;461-472.
49. Moczar M., Robert L. Action of human hyperlipidemic sera on the biosynthesis of intercellular matrix macromolecules in aorta organ cultures. Paroi. Artérielle. 3:1976;105-113.
50. Bonithon-Kopp C., Touboul P.J., Berr C. et al. Relation of intima-media thickness to atherosclerotic plaques in carotid arteries. Arterioscler. Thromb. Vasc. Biol. 16:1996;310-316.
51. Bonithon-Kopp C., Touboul P.J., Berr C., Magne C., Ducimetiere P. Factors of carotid arterial enlargement in a population aged 59 to 71 years. The EVA Study. Stroke. 27:1996;654-660.
52. Bizbiz L., Bonithon-Kopp C., Ducimetiere P., Berr C., Alperovitch A., Robert L. Relation of serum elastase activity to ultrasonographically assessed carotid artery wall lesions and cardiovascular risk factors. The EVA study. Atherosclerosis. 120:1996;47-55.
53. Bizbiz L., Alperovitch A., Robert L. Aging of the vascular wall: serum concentration of elastin peptides and elastase inhibitors in relation with cardiovascular risk factor. The EVA study. Atherosclerosis. 131:1997;73-78.
54. Bizbiz L., Labat-Robert J., Alperovitch A., Robert L. Cardiovascular determinants of plasma fibronectin in an elderly population. The EVA study. Arch. Gerontol. Geriatr. 25:1997;201-209.
55. Labat-Robert J., Szendroi M., Godeau G., Robert L. Comparative distribution patterns of type I and III collagens and fibronectin in human arteriosclerotic aorta. Pathol. Biol. 33:1985;261-265.
56. Labat-Robert J., Potazman J.P., Derouette J.C., Robert L. Age-dependent increase of human plasma fibronectin. Cell. Biol. Int. 5:1981;969-973.
57. Labat-Robert J., Gruber E., Bihari-Varga M. Interaction between fibronectin proteoglycans and lipoproteins. Int. J. Biol. Macromol. 12:1990;50-54.
58. Goldstein JL, Brown MS. The low-density lipoprotein pathway and its relation to atherosclerosis. Ann Rev Biochem 1977;897-930.
59. Robert L. Aging of vascular wall and atherogenesis, Role of the elastin-laminin receptor. Atherosclerosis. 123:1996;169-179.
60. Faury G., Ristori M.T., Verdetti J., Jacob M.P., Robert L. Effect of elastin peptides on vascular tone. J. Vasc. Res. 32:1995;112-119.
61. Faury G., Chabaud A., Ristori M.T., Robert L., Verdetti J. Effect of age on the vasodilatory action of elastin peptides. Mech. Ageing. Dev. 95:1997;31-42.
62. Faury G., Garnier S., Weiss A.S. et al. Action of tropoelastin and synthetic elastin sequences on vascular tone and on endothelial calcium signaling. Circ. Res. 82:1998;328-336.
63. Mecham R.P., Hinek A., Entwistle R., Wrenn D.S., Griffin G.L., Senior R.M. Elastin binds to a multifunctional 67-kDa peripheral membrane protein. Biochemistry. 28:1989;3716-3722.
64. Hauck M., Seres I., Kiss I., Saulnier J., Mohacsi A., Wallach J., Fulop T. Effects of synthesized elastin peptides on human leukocytes. Biochem. Mol. Biol. Int. 37:1995;45-55.
65. Varga Z., Jacob M.P., Csongor J., Robert L., Leovey A., Fulop T. Jr Altered phosphatidylinositol breakdown after K-elastin stimulation in PMBls of elderly. Mech. Ageing. Dev. 52:1990;61-70.
66. Faury G., Usson Y., Robert-Nicoud M., Robert L., Verdetti J. Nuclear and cytoplasmic free calcium level changes induced by elastin peptides in human endothelial cells. Proc. Natl. Acad. Sci. USA. 95:1998;2967-2972.
67. Varga Z., Jacob M.P., Robert L., Fulop T. Jr Identification and signal transduction mechanism of elastin peptide receptor in human leukocytes. FEBS. Lett. 258:1989;5-8.
68. Ghuysen-Itard A.F., Robert L., Gourlet V., Berr C., Jacob M.P. Loss of calcium - homeostatic mechanisms in polymorphonuclear leukocytes of demented and nondemented elderly subjects. Gerontology. 39:1993;163-169.
69. Peterszegi G, Robert L. Cell death induced in lymphocytes expressing the elastin-laminin receptor by excess agonists: necrosis and apoptosis. Biomed Pharmacother 1998, in press.
70. Varga Z.S., Jacob M.P., Robert L., Csongor J., Fulop T. Age-dependent changes of k-elastin stimulated effector functions of human phagocytic cells. Relevance for atherogenesis. Exp. Gerontol. 32:1997;653-662.
71. Roth G.S., Joseph J.A., Mason R.P. Membrane alterations as causes of impaired signal transduction in Alzheimer's disease and aging. Trends. Neural. Sci. 18:1995;203-206.
72. Miyamoto A., Roth G.S. Changes in transmembrane signaling mechanisms during aging - cellular and molecula aspects. Mecieira-Coelho A. Molecular basis of aging. 1995;293-306 CRC Press, Boca Raton, FL.
73. Peterszegi G., Texier S., Robert L. Human helper and memory lymphocytes exhibit an inducible elastin-laminin receptor. Int. Arch. Allergy. Immunol. 114:1997;218-223.
74. Peterszegi G., Mandet C., Texier S., Robert L., Bruneval P. Lymphocytes in human atherosclerotic plaque exhibit the elastin-laminin receptor: potential role in atherogenesis. Atherosclerosis. 135:1997;103-107.
75. Senior R.M., Hinek A., Griffin G.L., Pipoly D.J., Crouch E.C., Mecham R.P. Neutrophils show chemotaxis to type IV collagen and its 7S domain and contain a 67 kDa type IV collagen binding protein with lectin properties. Am. J. Respir. Cell. Mol. Biol. 1:1989;479-487.
76. Robert A.M., Grosgogeat Y., Reverdy V., Robert B., Robert L. Lésions artérielles produites chez le lapin par immunisation avec l'élastine et les glycoprotéines de structure de l'aorte. Etudes biochimiques et morphologiques. Atherosclerosis. 13:1971;427-449.
77. Jacob M.P., Hornebeck W., Lafuma C., Bernaudin J.F., Robert L., Godeau G. Ultrastructural and biochemical modifications of rabbit arteries induced by immunization with soluble elastin peptides. Exp. Mol. Pathol. 41:1984;171-190.
78. Stone P.J., Lucey E.C., Snider G.L., Franzblau C. Distribution of elastin in hamsters and the turnover rates of different elasin pools (44118). Proc. Soc. Exp. Biol. Med. 215:1997;94.
79. Campbell G.R., Campbell J.H. Smooth muscle cells. Olsson A.G. Atherosclerosis biology and clinical science. 1987;105-115 Churchill Livingstone, Edinburgh.
80. Li D.Y., Brooke B., Davis E.C., Mecham R.P., Sorensen L.K., Boak B.B., Eichwald E., Keating M.T. Elastin is an essential determinant of arterial morphogenesis. Nature. 393:1998;276-280.
81. Koyama H., Raines E.W., Bornfeldt K.E., Roberts J.M., Ross R. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell. 87:1996;1069-1078.
82. Bornfeldt K.E., Raines E.W., Graves L.M., Skinner M.P., Krebs E.G., Ross R. Platelet-derived growth factor. Recept. Act. Antigens. Cytokines. Hormones. Growth. Factors. 766:1996;416.
83. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801.
84. Yamamoto H., Crow M., Cheng L., Lakatta E., Kinsella J. PDGF receptor-to-nucleus signaling of p91 (STAT1α) transcription factor in rat smooth muscle cells. Exp. Cell. Res. 222:1996;125-130.
85. Colaco C.A.L.S. The glycation hypothesis of atherosclerosis. 1997;Springer, New York.
86. Bruel A., Oxlund H. Changes in biomechanical properties, composition of collagen and elastin, and advanced glycation endproducts of the rat aorta in relation to age. Atherosclerosis. 127:1996;155-165.